The chemopreventive and chemotherapeutic potentials of tea polyphenols

Current Pharmaceutical Biotechnology

Volumn 13, Issue 1, 2012, Pages 191-199

  Thakur, Vijay S ^a,b   Gupta, Karishma ^a   Gupta, Sanjay ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Angiogenesis; Apoptosis; Cancer; Epigenetics; Green tea; Metastasis; Tea catechins

Indexed keywords

CATECHIN; CYCLOOXYGENASE 2; DOXORUBICIN; EPICATECHIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; FLAVONOL; GALLIC ACID; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRILYSIN; METHYLXANTHINE; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR; POLYPHENOL DERIVATIVE; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; QUINIC ACID; SOMATOMEDIN; THEAFLAVIN; THEANINE; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL DIVISION; CHEMOPROPHYLAXIS; COLON CANCER; DNA DAMAGE; DNA METHYLATION; EPIGENETICS; HUMAN; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEA;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; NEOPLASMS; POLYPHENOLS; TEA;

ANIMALIA; CAMELLIA SINENSIS;

EID: 84862931922     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112798868584     Document Type: Article

References (68)

1. Herceg, Z.; Hainaut, P. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol. Oncol., 2007, 1(1), 26-41.
2. Siddiqui, I.A.; Adhami, V.M.; Saleem, M.; Mukhtar, H. Beneficial effects of tea and its polyphenols against prostate cancer. Mol. Nutr. Food Res., 2006, 50(2), 130-143.
3. Boehm, K.; Borrelli, F.; Ernst, E.; Habacher, G.; Hung, S.K.; Milazzo, S.; Horneber, M. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database of Syst. Rev., 2009, 3, CD005004.
4. Maddika, S.; Ande, S.R.; Panigrahi, S.; Paranjothy, T.; Weglarczyk, K.; Zuse, A.; Eshraghi, M.; Manda, K.D.; Wiechec, E,; Los, M. Drug Resist. Updat., 2007, 10(1-2), 13-29.
5. Clement Y. Can green tea do that? A literature review of the clinical evidence. Prev. Med., 2009, 42(2-3), 83-87.
6. Kumar, G.; Pillare, S.P.; Maru, G.B. Black tea polyphenolsmediated in vivo cellular responses during carcinogenesis. Med. Chem., 2010, 10(6), 492-505.
7. Khan, N.; Adhani, V.M.; Mukhtar, H. Review: Green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr. Cancer, 2009, 61(6), 836-841.
8. Ramos, S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem., 2007, 18(7), 427-442.
9. Huang, C.H.; Tsai, S.J.; Wang, Y.J.; Pan, M.H.; Kao, J.Y.; Way, T.D. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol. Nutr. Food Res., 2009, 53(9), 1156-1165.
10. Beltz, L.A.; Bayer, D.K.; Moss, A.L.; Simet, I.M. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med. Chem., 2006, 6(5), 389-406.
11. Yamauchi, R.; Sasaki, K.; Yoshida, K. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549. Toxicol. In Vitro., 2009, 23(5), 834-839.
12. Qanungo, S.; Das, M.; Haldar, S.; Basu, A. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis, 2005, 26(5), 958-967.
13. Yang, C.S.; Wang, X.; Lu, G.; Picinich, S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer, 2009, 9(6), 429-439.
14. Baek, S.J.; Kim, J.S.; Jackson, F.R.; Eling, T.E.; McEntee, M.F.; Lee, S.H. Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis, 2004, 25(12), 2425-2432.
15. Nie, G.; Jin, C.; Cao, Y.; Shen, S.; Zhao, B. Distinct effects of tea catechins on 6 hydroxydopamine-induced apoptosis in PC12 cells. Arch. Biochem. Biophys., 2002, 397(1),84-90.
16. Amin, A.R.; Thakur, V.S.; Paul, R.K.; Feng, G.S.; Qu, C.K.; Mukhtar, H.; Agarwal, M.L. SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG. Proc. Natl. Acad. Sci. USA., 2007, 104(13), 5419-5424.
17. Basu, A.; Haldar, S. Combinatorial effect of epigallocatechin-3-gallate and TRAIL on pancreatic cancer cell death. Int. J. Oncol., 2009, 34(1), 281-286.
18. Thakur, V.S.; Ruhul Amin, A.R.; Paul, R.K.; Gupta, K.; Hastak, K.; Agarwal, M.K.; Jackson, M.W.; Wald, D.N.; Mukhtar, H.; Agarwal, M.L. p53-Dependent p21-mediated growth arrest preempts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG. Cancer Lett., 2010, 296(2), 225-232.
19. Luo, K.L.; Luo, J.H.; Y.P. (-)-Epigallocatechin-3-gallate induces DU145 prostate cancer cell death via downregulation of inhibitor of DNA binding 2, a dominant negative helix-loop-helix protein. Cancer Sci., 2010, 103(3), 707-712.
20. Gu, Q.; Hu, C.; Chen, Q.; Xia, Y.; Feng, J.; Yang, H. Development of a rat model by 3,4-benzopyrene intra-pulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl-2 expression in lung carcinoma. Cancer Detect. Pev., 2009, 32(5-6), 444-451.
21. Wu, P.P.; Kuo, S.C.; Huang, W.W.; Yang, J.S.; Lai, K.C.; Chen, H.J.; Lin, K.L.; Chiu, Y.J.; Huang, L.J.; Chung, J.G. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspaseindependent pathway. Anticancer Res., 2009, 29(4), 1435-1442.
22. Kim, M.J.; Kim, H.I.; Chung, J.; Jeong, T.S.; Park, H.R. (-)-Epigallocatechin-3-gallate (EGCG) increases the viability of serum-starved A549 cells through its effect on Akt. Am. J. Chin. Med., 2009, 37(4), 723-734.
23. Shimizu, M.; Shirakami, Y.; Moriwaki, H. Targeting receptor tyrosine kinases for chemoprevention by green tee catechin EGCG. Int. J. Mol. Sci., 2008, 9(6), 1034-1049.
24. Yokoyama, S.; Hirano, H.; Wakimaru, N.; Sarker, K.P.; Kuratsu, J. Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro. Neuro. Oncol., 2001, 3(1), 22-28.
25. Adhami, V.M.; Siddiqui, I.A.; Sarfaraz, S.; Khwaja, S.I.; Hafeez, B.B.; Ahmad, N.; Mukhtar, H. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin. Cancer Res., 2009, 15(6), 1947-1953.
26. McLarty, J.; Bigelow, R.L.; Smith, M.; Elmajian, D.; Ankem, M.; Cardelli, J.A. Tea polyphenols decrease serum levels of prostatespecific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev. Res. (Phila. Pa), 2009, 2(7), 2673-2682.
27. Katiyar, S.; Elmets, C.A.; Katiyar, S.K. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J. Nutr. Biochem., 2007, 18(5), 287-296.
28. Adachi, S.; Shimizu, M.; Shirakami, Y.; Yamauchi, J.; Natsume, H.; Matsushima Nishiwaki, R.; To, S.; Weinstein, I.B.; Moriwaki, H.; Kozawa. O. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells. Carcinogenesis, 2009, 30(9), 1544-1552.
29. Sakata, R.; Ueno, T.; Nakamura, T.; Sakamoto, M.; Torimura, T.; Sata, M. Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. J. Hepatol., 2004, 40(1), 52-59.
30. Tachibana, H. Molecular basis for cancer chemoprevention by green tea polyphenol EGCG. Forum Nutr., 2009, 61, 156-169.
31. Patra, S.K.; Rizzi, F.; Silva, A.; Rugina, D.O.; Bettuzzi, S. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J. Physiol Pharmacol., 2008, 59(Suppl 9), 217-235.
32. Khan, N.; Mukhtar, H. Multitargted therapy of cancer by green tea polyphenols. Cancer Lett., 2008, 269(2), 269-280.
33. Li, W.G.; Li, Q.H.; Tan, Z. Epigallocatechin gallate induces telomere fragmentation in HeLa and 293 but not in MRC-5 cells. Life Sci., 2005, 76(15), 1735-1746.
34. Slivova. V.; Zaloga, G.; DeMichele, S.J.; Mukerji, P.; Huang, Y.S.; Siddiqui, R.; Harvey, K.; Valachovicova, T.; Sliva. D. Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells. Nutr. Cancer, 2005, 52(1), 66-73.
35. Maeda-Yamamoto, M.; Kawahara, H.; Tahara, N.; Tsuji, K.; Hara, Y.; Isemura, M. Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells. J. Agric. Food Chem., 1999, 47(6), 2350-2354.
36. Sen, T.; Moulik, S.; Dutta, A.; Roy Choudhury, P.; Banerji, A.; Das, S.; Roy, M.; Chatterjee, A. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci., 2009, 84(7-8), 194-204.
37. Larsen, C.A.; Dashwood, R.H. Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: Minor role of hydrogen peroxide. Biochem. Biophys. Res. Commun., 2009, 389(3), 527-530.
38. Larsen, C.A.; Bisson, W.H.; Dashwood, R.H. Tea catechins inhibit hepatocyte growth factor receptor (MET Kinase) activity in human colon cancer cells: Kinetic and molecular docking studies. J. Med. Chem., 2009, 52(21), 6543-6545.
39. Kushima, Y.; Iida, K.; Nagaoka, Y.; Kawaratani, Y.; Shirahama, T.; Sakaguchi, M.; Baba, K.; Hara, Y.; Uesato, S. Inhibitory effect of (-)-epigallocatechin and (-) epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biol. Pharm. Bull., 2009, 32(5), 899-904.
40. Shankar, S.; Ganapathy, S.; Hingorani, S.R.; Srivastava, R.K. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front. Biosci., 2008, 13, 440-452.
41. Liu, J.D.; Chen, S.H.; Lin, C.L.; Tsai, S.H.; Liang, Y.C. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice. J. Cell Biochem., 2001, 83(4), 631-642.
42. Kim, M.; Murakami, A.; Kawabata, K.; Ohigashi, H. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells. Carcinogenesis, 2005, 26(9), 1553-1562.
43. Link, A.; Balaguer, F.; Goel, A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetic. Biochem. Pharmacol., 2010, 80(12), 1771-1792.
44. Jia, D.; Jurkowska. R.Z.; Zhang, X.; Jeltsch, A.; Cheng, X. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature, 2007, 449(7159), 248-251.
45. Feinberg, A.P.; Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature, 1983, 301(5895), 89-92.
46. Ehrlich, M. DNA methylation in cancer: Too much, but also too little. Oncogene., 2002, 21(35), 5400-5413.
47. Jones. P. A; Baylin, S.B. The epigenomics of cancer. Cell, 2007, 128(4), 683-692.
48. Sharma, G.; Mirza, S.; Yang, Y.H.; Parshad, R.; Hazrah, P.; Datta Gupta, S.; Ralhan, R. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell. Oncol., 2009, 31(6), 487-500.
49. Holloway, A.F.; Oakford, P.C. Targeting epigenetic modifiers in cancer. Curr. Med. Chem., 2007, 14(24), 2540-2547.
50. Myzak, M.; Dashwood, R.H. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr. Drug Targets, 2006, 7(4), 443-452.
51. Glozak, M.A.; Seto, E. Histone deacetylases and cancer. Oncogene., 2007, 26(37), 5420-5432.
52. Kuzuhara, T.; Tanabe, A.; Sei, Y.; Yamaguchi, K.; Suganuma, M.; Fujiki, H. Synergistic effects of multiple treatments, and both DNA and RNA direct bindings on, green tea catechins. Mol Carcinog., 2007, 46(8), 640-645.
53. Ran, Z.H.; Zou, J.; Xiao, S.D. Experimental study on antineoplastic activity of epigallocatechin-3-gallate to digestive tract carcinomas. Chin. Med. J. (Engl.)., 2005, 118(16), 1330-1337.
54. Xiao, G.S.; Jin, Y.S.; Lu. Q.Y.; Zhang, Z.F.; Belldegrun, A.; Figlin, R.; Pantuck, A.; Yen, Y.; Li, F.; Rao, J. Annexin-I as a potential target for green tea extract induced actin remodeling. Int. J. Cancer, 2007, 120(1), 111-120.
55. Nakagawa, K.; Miyazawa, T. Chemiluminescence-Highperformance liquid chromatographic determination of tea catechin, (α)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma. Anal. Biochem., 1997, 248(1), 41-49.
56. Lam, W.H.; Kazi, A.; Kuhn, D.J.; Chow, L.M.C.; Chan, A.S.C.; Dou, Q.P.; Chan, T.H. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]. Bioorg. Med. Chem., 2004, 12(21), 5587-5593.
57. Landis-Piwowar, K.R.; Milacic, V.; Dou, Q.P. Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cells. J. Cell. Biochem., 2008, 105(2), 514-523.
58. Sánchez-del-Campo, L.; Tárraga, A.; Montenegro, M.F.; Cabezas-Herrera, J.; Rodríguez-López, J.N. Melanoma activation of 3-o-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin to a potent irreversible inhibitor of dihydrofolate reductase. Mol. Pharm., 2009, 6(3), 883-894.
59. Henning, S.M.; Choo, J.J.; Heber, D. Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J. Nutr., 2008, 138(8), 1529S-1534S.
60. Bode, A.M.; Dong, Z. Epigallocatechin 3-Gallate and Green Tea Catechins: United they work, divided they fail. Cancer Prev. Res., 2009, 2(6), 514-517.
61. Siddiqui, I.A.; Adhami, V.M.; Bharali, D.J.; Hafeez, B.B.; Asim, M.; Khwaja, S.I.; Ahmad, N.; Cui, H.; Mousa, S.A.; Mukhtar, H. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res., 2009, 69(5), 1712-1716.
62. Amin, A.R.; Khuri, F.R.; Chen, Z.G.; Shin, D.M. Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB. Cancer Prev. Res. (Phila Pa), 2009, 2(6), 538-545.
63. Hu, L.; Miao, W.; Loignon, M., Kandouz, M., Batist, G. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies. Cancer Chemother. Pharmacol., 2010, 66(3), 467-474.
64. Muto, S.; Fujita, K.; Yamazaki, Y.; Kamataki, T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res., 2001, 479(1-2), 197-206.
65. Jang, E.H.; Choi, J.Y.; Park, C.S.; Lee, S.K.; Kim, C.E.; Park, H.J.; Kang, J.S.; Lee, J.W. and Kang, J.H. Effects of green tea extract administration on the pharmacokinetics of clozapine in rats. J. Pharm. Pharmacol., 2005, 57(3), 311-316.
66. Dudka, J.; Jodynis-Liebert, J.; Korobowicz, E.; Burdan, F.; Korobowicz, A.; Szumilo, J.; Tokarska, E.; Klepacz, R.; Murias, M. Activity of NADPH-cytochrome P-450 reductase of the human heart, liver and lungs in the presence of (-)-epigallocatechin gallate, quercetin and resveratrol: an in vitro study. Basic Clin. Pharmacol. Toxicol., 2005, 97(2), 74-79.
67. Kim, T.Y.; Park, J.; Oh, B.; Min, H.J.; Jeong, T.S.; Lee, J.H.; Suh, C. Cheong, J.W.; Kim, H.J.; Yoon, S.S.; Park, S.B.; Lee. D.S. Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction. Br. J. Haematol. 2009, 146(3), 270-281.
68. Golden, E.B.; Lam, P.Y.; Kardosh, A.; Gaffney, K.J.; Cadenas, E.; Louie, S.G.; Petasis, N.A.; Chen, T.C.; Schönthal, A.H. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood, 2009, 113(23), 5927-5937.